1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,191 | 0,193 | 10:25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 20.02. | Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan | 406 | Business Wire | Reserved issuance of warrants for convertible bonds based on a fixed price per share of 0.20 euros (without discount), for a maximum amount of €6 million, benefiting Furui and Unigestion, the... ► Artikel lesen | |
| 11.02. | Theraclion Announces Treatment of First Patients With New SONOVEIN 'SpeedPulse' Feature Accelerating Treatment | 260 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 07.02. | Theraclion: Publication of Adjusted Accounts for the First Half of 2024 | 336 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment... ► Artikel lesen | |
| 06.01. | Theraclion Reviews Its 2024 Achievements | 271 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment... ► Artikel lesen | |
| 30.10.24 | Theraclion Announces Major Advances and Reports First-Half Financial Results | 445 | Business Wire | On the strength of its progress on its 2023 and 2024 priorities (access to the US market, R&D and China), Theraclion is planning its commercial ramp-up for 2025 and 2026. Pivotal study for... ► Artikel lesen | |
| 06.09.24 | Theraclion Confirms Strong Mid-Year Achievements | 410 | Business Wire | Main focus: Access to the U.S. market, R&D and China. Key achievements in H1 2024: FDA pivotal study: treatments completed in June on schedule
Promising R&D progress in product features... ► Artikel lesen | |
| 24.06.24 | SONOVEIN FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule | 633 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE) innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy... ► Artikel lesen | |
| 06.06.24 | Theraclion: SONOVEIN Highlighted in Top Medical Conferences and Scientific Journal | 544 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 27.03.24 | Theraclion Announces 2023 Financial Results and Continues Its Roadmap | 366 | Business Wire | Continuation of the strategy focused on access to the US and Chinese markets for SONOVEIN®, and its improvement through R&D;
Rapid start-up of the pivotal study in the United States: two-thirds... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 80,30 | -0,43 % | Neue Fantasie bei Gerresheimer | Die Aktie von Gerresheimer zog jüngst nach Übernahmespekulationen kräftig an. Der Hersteller von Spezialverpackungen für die Pharma- und Kosmetikindustrie ist offensichtlich in das Visier von Aufkäufern... ► Artikel lesen | |
| INMODE | 17,505 | -2,86 % | InMode LTD.: InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program | Quarterly GAAP revenues of $97.9 million and full year revenue of $394.8 million
Returned $285.4 million of capital to shareholders in full year 2024
Together with... ► Artikel lesen | |
| MCKESSON | 611,80 | -0,52 % | Dividendenbekanntmachungen (03.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALIGHT INC US01626W1018 0,04 USD 0,0385 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,27 USD 0,2602 EUR ASSOCIATED BANC-CORP US0454871056 0... ► Artikel lesen | |
| HCA HEALTHCARE | 298,60 | +0,50 % | Mn Services Vermogensbeheer B.V. Has $23.68 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA) | ||
| LIMES SCHLOSSKLINIKEN | 320,00 | 0,00 % | EQS-Adhoc: Limes Schlosskliniken AG: Vorläufiges Konzernergebnis 2024 (untestiert) / Prognose 2025 | EQS-Ad-hoc: Limes Schlosskliniken AG / Schlagwort(e): Jahresergebnis/Prognose
Limes Schlosskliniken AG: Vorläufiges Konzernergebnis 2024 (untestiert) / Prognose 2025
25.02.2025 / 10:31 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BEYOND AIR | 0,256 | +3,23 % | Beyond Air Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update | Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for LungFit PH® in Europe and Market Authorization in Australia; international... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 10,100 | +1,51 % | HCSG Reports Q4 2024 Results | BENSALEM, Pa.--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended December 31, 2024.
Ted Wahl, Chief Executive Officer, stated, "2024... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 1,140 | 0,00 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results | Q4 and FY Test volume increase 21% and 17% year-over-year -Q4 and FY Volume, Revenue, and Profitability at all-time record levels PARSIPPANY, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences... ► Artikel lesen | |
| SIENNA SENIOR LIVING | 10,200 | 0,00 % | Dividendenbekanntmachungen (28.02.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,32 USD 0,3078 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,16 USD 0,1539 EUR AGNC INVESTMENT... ► Artikel lesen | |
| ADDUS HOMECARE | 89,00 | -1,66 % | RBC Capital cuts Addus HomeCare price target to $133, keeps Outperform | ||
| IVF HARTMANN | 152,03 | +1,45 % | IVF Hartmann 2024 mit deutlich mehr Gewinn | Neuhausen am Rheinfall - Der Medizinalbedarfhersteller IVF Hartmann hat 2024 mehr Umsatz erzielt und mehr verdient. Den Aktionären winkt trotzdem eine tiefere Dividende. Der Umsatz von IVF Hartmann... ► Artikel lesen | |
| MODERN DENTAL | 0,466 | -0,85 % | EQS Newswire: Modern Dental Group Limited: Modern Dental Group Announces 2024 Third Quarter Operational Update | EQS Newswire / 29/11/2024 / 09:00 UTC+8
(28 November 2024, Hong Kong) - Modern Dental Group Limited ("Modern Dental" or "the Group", stock code: 03600.HK), a leading global dental prosthetic... ► Artikel lesen | |
| ICU MEDICAL | 145,00 | +6,62 % | ICU Medical stock holds steady after Needham maintains rating | ||
| PROGYNY | 22,000 | 0,00 % | Progyny, Inc. Announces Fourth Quarter 2024 Results | Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 43,750 | -7,82 % | DAX schwächer erwartet: Rheinmetall, FMC und Heidelberg Materials im Fokus | Dem Erholungsversuch des DAX geht am Dienstag bereits wieder etwas die Luft aus. Der Broker IG taxierte den deutschen Leitindex rund drei Stunden vor dem Handelsstart knapp 0,3 Prozent tiefer auf 22.361... ► Artikel lesen |
Das Unternehmen THERACLION kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,183 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION finden Sie auf Wallstreet Online.
